Abstract
Roux-en-Y gastric bypass surgery (RYGB) has shown efficacy in weight loss, but its role in liver fibrosis remains unknown and contentious. The present study aimed to investigate the effect of RYGB on liver fibrosis measured by non-invasive methods and assess the impact of weight loss on hepatic fibrosis in the midterm follow-up after RYGB. This longitudinal study was conducted on patients with extreme obesity, and NAFLD referred for RYGB during 2016–2018 for 3 years after their surgery. A liver biopsy was performed intraoperatively. The patient demographics, anthropometrical parameters, biochemical variables, and Liver stiffness (LS) using two-dimensional shear-wave elastography were recorded and analyzed before and in short-term and midterm follow-ups. Fifty-four patients were included with a mean age of 40.3 years; 83.3% were women. At a median follow-up of 30 months (range: 24–36 months), the excessive body mass index loss of the patients was 78.1% and, a significant reduction was seen in LS measurement. Two patients (4%) had worsening showed in the fibrosis stage, 28 (54%) no change, and 24 (42%) showed improvement, 30 months after the surgery. Moreover, the liver fibrosis stage regressed to F0 in 91% of the patients. Hepatic fibrosis resolved in the midterm follow-up in some patients whose fibrosis had progressed and deteriorated in the short-term follow-up. In addition, Liver enzymes were decreased. RYGB seems to be an effective procedure for sustained weight loss and improved liver fibrosis in EO and NAFLD patients in midterm follow-up.
Graphical Abstract
Similar content being viewed by others
Availability of data
The datasets generated during and analysed during the current study are available from the corresponding author on reasonable request.
References
Garb J, Welch G, Zagarins S, Kuhn J, Romanelli J (2009) Bariatric surgery for the treatment of morbid obesity: a meta-analysis of weight loss outcomes for laparoscopic adjustable gastric banding and laparoscopic gastric bypass. Obes Surg 19:1447–1455
Nickel F, Tapking C, Benner L, Sollors J, Billeter AT, Kenngott HG et al (2018) Bariatric surgery as an efficient treatment for non-alcoholic fatty liver disease in a prospective study with 1 year follow-up. Obes Surg 28:1342–1350
Keleidari B, Mahmoudieh M, Kafi S, Shahabi S, Sheikhbahaei E, Farahmand A et al (2020) Which one is better for non-alcoholic fatty liver disease, the Roux-en-Y gastric bypass or one anastomosis gastric bypass? A paired liver biopsy report. Obesity Medicine 18:100205
Gu L, Huang X, Li S, Mao D, Shen Z, Khadaroo PA et al (2020) A meta-analysis of the medium- and long-term effects of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass. BMC Surg 20:30
Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD et al (2005) Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg 15:310–315
Wirth KM, Sheka AC, Kizy S, Irey R, Benner A, Sieger G et al (2020) Bariatric surgery is associated with decreased progression of nonalcoholic fatty liver disease to cirrhosis: a retrospective cohort analysis. Ann Surg 272:32–39
Borges-Canha M, Neves JS, Mendonça F, Silva MM, Costa C, Cabral PM et al (2020) The impact of bariatric surgery on hepatic function and predictors of liver steatosis and fibrosis. Obes Surg 30:2935–2941
Elnahas A, Nguyen GC, Okrainec A, Quereshy F, Jackson TD (2014) The effect of underlying liver disease on short-term outcomes following bariatric surgery. Surg Endosc 28:2708–2712
Brolin RE, Bradley LJ, Taliwal RV (1998) Unsuspected cirrhosis discovered during elective obesity operations. Arch Surg 133:84–88
Mosko JD, Nguyen GC (2011) Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol 9:897–901
Parker BM, Wu J, You J, Barnes DS, Yerian L, Kirwan JP et al (2017) Reversal of fibrosis in patients with nonalcoholic steatohepatosis after gastric bypass surgery. BMC obesity 4:1–9
Younossi ZM, Loomba R, Anstee QM, Rinella ME, Bugianesi E, Marchesini G et al (2018) Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis. Hepatology 68:349–360
Bâldea V, Sporea I, Lupușoru R, Bende F, Mare R, Popescu A et al (2020) Comparative study between the diagnostic performance of point and 2-D shear-wave elastography for the non-invasive assessment of liver fibrosis in patients with chronic hepatitis c using transient elastography as reference. Ultrasound Med Biol 46:2979–2988
Chimoriya R, Piya MK, Simmons D, Ahlenstiel G, Ho V (2021) The use of two-dimensional shear wave elastography in people with obesity for the assessment of liver fibrosis in non-alcoholic fatty liver disease. J Clin Med 10:95
Jamialahmadi T, Nematy M, Jangjoo A, Goshayeshi L, Rezvani R, Ghaffarzadegan K et al (2019) Measurement of liver stiffness with 2D-shear wave elastography (2D-SWE) in bariatric surgery candidates reveals acceptable diagnostic yield compared to liver biopsy. Obes Surg 29:2585–2592
Andersson D, Dahlman I, Eriksson Hogling D, Bäckdahl J, Toft E, Qvisth V et al (2019) Improved metabolism and body composition beyond normal levels following gastric bypass surgery: a longitudinal study. J Intern Med 285:92–101
O’Kane M, Parretti HM, Hughes CA, Sharma M, Woodcock S, Puplampu T et al (2016) Guidelines for the follow-up of patients undergoing bariatric surgery. Clinical obesity 6:210–224
Mahawar KK (2018) Defining short-term, medium-term, long-term, and very long-term follow-up after bariatric surgery. Obes Surg 28:1425–1426
Jamialahmadi T, Jangjoo A, Rezvani R, Goshayeshi L, Tasbandi A, Nooghabi MJ et al (2020) Hepatic function and fibrosis assessment via 2D-shear wave elastography and related biochemical markers pre-and post-gastric bypass surgery. Obesity Surg 30(6):1–8
Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA (2011) Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 53:810–820
Cheah MC, McCullough AJ, Goh GB-B. 2017 Current modalities of fibrosis assessment in non-alcoholic fatty liver disease. Journal of clinical and translational hepatology. https://doi.org/10.14218/JCTH.2017.00009.
Mansoor S, Collyer E, Alkhouri N (2015) A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic fatty liver disease. Curr Gastroenterol Rep 17:1–7
Corcelles R, Boules M, Froylich D, Hag A, Daigle CR, Aminian A et al (2016) Total weight loss as the outcome measure of choice after roux-en-Y gastric bypass. Obes Surg 26:1794–1798
**e X, Feng Y, Lyu Z, Wang L, Yang Y, Bai Y et al (2021) Liver stiffness as measured by two-dimensional shear wave elastography overestimates the stage of fibrosis in patients with chronic hepatitis B and hepatic steatosis. Clin Res Hepatol Gastroenterol 45:101421
Tannaz J, Ali J, Reza R, Ladan G, Aida T, Jabbari NM et al (2020) Hepatic function and fibrosis assessment via 2D-shear wave elastography and related biochemical markers pre-and post-gastric bypass surgery. Obes Surg 30:2251–2258
Taitano AA, Markow M, Finan JE, Wheeler DE, Gonzalvo JP, Murr MM (2015) Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointest Surg 19:429–437
Cazzo E, Pareja JC, Chaim EA (2017) Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review. Sao Paulo Med J 135:277–295
Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK (2008) Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 6:1396–1402
Fakhry TK, Mhaskar R, Schwitalla T, Muradova E, Gonzalvo JP, Murr MM (2019) Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis. Surg Obesity Relat Dis 15:502–511
Lassailly G, Caiazzo R, Ntandja-Wandji LC, Gnemmi V, Baud G, Verkindt H et al (2020) Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis. Gastroenterology 159:1290–301.e5
Caiazzo R, Lassailly G, Leteurtre E, Baud G, Verkindt H, Raverdy V et al (2014) Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5 year controlled longitudinal study. Ann Surg 260:893–899
Aminian A, Al-Kurd A, Wilson R, Bena J, Fayazzadeh H, Singh T et al (2021) Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis. JAMA 326:2031–2042
Bower G, Athanasiou T, Isla AM, Harling L, Li JV, Holmes E et al (2015) Bariatric surgery and nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 27:755–768
Ashrafian H, le Roux CW, Rowland SP, Ali M, Cummin AR, Darzi A et al (2012) Metabolic surgery and obstructive sleep apnoea: the protective effects of bariatric procedures. Thorax 67:442–449
Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R et al (2009) Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 137:532–540
Wong VW-S, Wong GL-H, Choi PC-L, Chan AW-H, Li MK-P, Chan H-Y et al (2010) Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 59:969–974
Naveau S, Lamouri K, Pourcher G, Njiké-Nakseu M, Ferretti S, Courie R et al (2014) The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD. Obes Surg 24:1693–1701
Müller-Stich BP, Fischer L, Kenngott HG, Gondan M, Senft J, Clemens G et al (2013) Gastric bypass leads to improvement of diabetic neuropathy independent of glucose normalization—results of a prospective cohort study (DiaSurg 1 study). Ann Surg 258:760–766
Kenngott HG, Clemens G, Gondan M, Senft J, Diener MK, Rudofsky G et al (2013) DiaSurg 2 trial-surgical vs. medical treatment of insulin-dependent type 2 diabetes mellitus in patients with a body mass index between 26 and 35 kg/m 2: study protocol of a randomized controlled multicenter trial-DRKS00004550. Trials 14:1–10
Jorge JM, Golas A, Patel N, Gonzalvo JP, Murr MM (2020) Management of nonalcoholic fatty liver disease and the role of bariatric surgery: a brief review for surgeons. Surg Obesity Relat Dis 16:699–703
de Andrade AR, Cotrim HP, Alves E, Soares D, Rocha R, Almeida A et al (2008) Nonalcoholic fatty liver disease in severely obese individuals: the influence of bariatric surgery. Ann Hepatol 7:364–368
Loaeza-del-Castillo A, Paz-Pineda F, Oviedo-Cárdenas E, Sánchez-Avila F, Vargas-Vorácková F (2008) AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis. Ann Hepatol 7:350–357
Kolhe KM, Amarapurkar A, Parikh P, Chaubal A, Chauhan S, Khairnar H et al (2019) Aspartate transaminase to platelet ratio index (APRI) but not FIB-5 or FIB-4 is accurate in ruling out significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) in an urban slum-dwelling population. BMJ Open Gastroenterol 6:e000288
Acknowledgements
The authors are thankful to all patients for their assistance in completing the 24 h dietary recall questionnaire.
Funding
None declared.
Author information
Authors and Affiliations
Contributions
Protocol/project development: J, NO, N, J, R and, G. Data collection or management: NO, J, N, J. Data analysis: NO and K-R. Manuscript writing/editing: NO, JR, and K-R.
Corresponding authors
Ethics declarations
Conflicts of interest
The authors declare that they have no competing interests. None declared.
Ethical approval
All the procedures performed in this study that involved human participants were in accordance with the ethical standards of the institutional and/or national research committee and the Declaration of Helsinki (1964).
Informed consent
Informed consent was obtained from all the patients prior to enrollment.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Norouzian Ostad, A., Rajabzadeh, F., Jamialahmadi, T. et al. Impact of gastric bypass surgery on the liver fibrosis of patients with extreme obesity and nonalcoholic fatty liver disease in 30-month follow-up. Updates Surg 75, 659–669 (2023). https://doi.org/10.1007/s13304-022-01421-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13304-022-01421-3